Pharmaceutical composition containing crystalline macitentan

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9730932
SERIAL NO

14781681

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an oral solid dosage form, in particular a tablet, comprising macitentan free base polymorphic form I.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANDOZ INTERNATIONAL GMBHINDUSTRIESTR 25 HOLZKIRCHEN D-83607

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Englmeier, Ludwig Holzkirchen, DE 6 1
Raneburger, Johannes Kundl, AT 18 44
Stefinovic, Marijan Kundl, AT 11 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 15, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 15, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00